PDF herunterladen
CC BY-NC-ND 4.0 · World J Nucl Med 2022; 21(04): 342-344
DOI: 10.1055/s-0042-1750399
Case Report

Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT

Yousif A. Lucinian
1   Department of Medical Imaging, Institut de Cardiologie de Montréal, Montréal, Québec, Canada
,
Patrick Martineau
2   Functional Imaging, Cancer, Vancouver, British Columbia, Canada
3   Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
,
Matthieu Pelletier-Galarneau
1   Department of Medical Imaging, Institut de Cardiologie de Montréal, Montréal, Québec, Canada
4   Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

We present the case of a 65-year-old woman with known pulmonary and muscular sarcoidosis who presented with dyspnea. FDG-PET/CT revealed unsuspected active myositis of multiple muscle groups, including the neck, and was useful in monitoring treatment response.

Keywords

sarcoidosis - myositis - PET - FDG - fluoro-deoxyglucose


Publikationsverlauf

Artikel online veröffentlicht:
09. September 2022

© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Zisman DA, Shorr AF, Lynch III JP. Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med 2002; 23 (06) 555-570
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Schreiber T, Windisch W. Respiratory muscle involvement in sarcoidosis. Expert Rev Respir Med 2018; 12 (07) 545-548
    CrossrefPubMedGoogle Scholar
  • 3 Aptel S, Lecocq-Teixeira S, Olivier P, Regent D, Teixeira PG, Blum A. Multimodality evaluation of musculoskeletal sarcoidosis: imaging findings and literature review. Diagn Interv Imaging 2016; 97 (01) 5-18
    CrossrefPubMedGoogle Scholar
  • 4 Wieërs G, Lhommel R, Lecouvet F, Van den Bergh P, Lambert M. A tiger man. Lancet 2012; 380 (9856): 1859
    CrossrefPubMedGoogle Scholar
  • 5 Han EJ, Jang YS, Lee IS, Lee JM, Kang S, Kim HS. Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient. J Korean Med Sci 2013; 28 (09) 1399-1402
    CrossrefPubMedGoogle Scholar
  • 6 Kolilekas L, Triantafillidou C, Manali E, Rontogianni D, Chatziioannou S, Papiris S. The many faces of sarcoidosis: asymptomatic muscle mass mimicking giant-cell tumor. Rheumatol Int 2009; 29 (11) 1389-1390
    CrossrefPubMedGoogle Scholar
  • 7 Marie I, Lahaxe L, Vera P, Edet-Samson A. Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography. QJM 2010; 103 (12) 1000-1002
    CrossrefPubMedGoogle Scholar
  • 8 Baughman RP, Lower EE, Drent M. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25 (02) 76-89
    PubMedGoogle Scholar
  • 9 Dhomps A, Foret T, Streichenberger N, Skanjeti A, Tordo J. Isolated muscular sarcoidosis revealed by hypercalcemia and 18F-FDG PET/CT. Clin Nucl Med 2019; 44 (10) 824-825
    CrossrefPubMedGoogle Scholar